Arsenic trioxide (ATO) is used in the clinic for the treatment of acute promyelocytic leukemia by targeting the protein PML. However, many zinc-finger proteins could also be reactive to arsenic in cells. Here we found that ATO preferentially binds to the ring-finger domain of PML in a protein mixture with zinc-finger domains. These results provide the molecular basis of the target selection of ATO in cells.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1039/c8mt00202a | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!